Treatment | n | Inhibition (%)* | Doubling time (days)** | Absolute growth delay (days)*** | Normalized growth delay (days) | Enhancement factor |
---|---|---|---|---|---|---|
Control | 5 | 10.8 ± 1.2 | ||||
Ber5 | 5 | 27.6 ± 6.3 | 12.3 ± 2.5 | 1.5(12.3-10.8) | ||
Ber10 | 5 | 58.1 ± 8.6 | 13.1 ± 3.0 | 2.3(13.1-10.8) | ||
IR | 5 | 37.8 ± 6.9 | 16.5 ± 1.5 | 5.7(16.5-10.8) | ||
IR + Ber5 | 5 | 66.6 ± 9.2 | 21.4 ± 0.7 | 10.6(21.4-10.8) | 9.1(10.6-1.5) | 1.6(9.1/5.7) |
IR + Ber10 | 5 | 75.9 ± 5.9 | 22.7 ± 4.6 | 11.9(22.7-10.8) | 9.6(11.9-2.3) | 1.7(9.6/5.7) |